THOUSAND OAKS, Calif.--(BUSINESS WIRE)--July 18, 2006--Amgen
(Nasdaq:AMGN), the world´s largest biotechnology company, announced
that as part of its efforts to continuously improve its investor
communications, it intends to provide a slide presentation with its
upcoming second quarter financial results conference call, scheduled
for Thursday, July 20, 2006 at 2 p.m. Pacific Daylight Time. The slide
presentation will be posted in the Investor section of the company´s
Web site (www.amgen.com/investors) in advance of the company´s
conference call. Amgen expects the slide presentation to be available
on the Web site at or around the same time the company reports its
second quarter financial results after the financial markets close.
Amgen discovers, develops and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the
first companies to realize the new science´s promise by bringing safe
and effective medicines from lab, to manufacturing plant, to patient.
Amgen therapeutics have changed the practice of medicine, helping
millions of people around the world in the fight against cancer,
kidney disease, rheumatoid arthritis, and other serious illnesses.
With a broad and deep pipeline of potential new medicines, Amgen
remains committed to advancing science to dramatically improve
people´s lives. To learn more about our pioneering science and our
vital medicines, visit www.amgen.com.
CONTACT: Amgen, Thousand Oaks
Dan Whelan, 805-447-5995 (media)
Arvind Sood, 805-447-1060 (investors)